Sixty-three different proteins were identified in the first group and 50 in the second group. Recognition was possible for 28 proteins exclusively detected in Group 1 and 21 proteins presented only in Group 2.
Conclusion:
Some proteins in the first group are directly involved in the development of other types of cancer, and therefore, suitable for analysis. Complement C3protein is a strong candidate for evaluating SCCP patients.